SCHEMBL11025738

SCHEMBL11025738

CCOC(=O)Nc1ccc(Cl)cc1CCC(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.46
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ HPGD P15428 1/20 0.45
▸ MAPT P10636 5/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ GRM5 P41594 1/20 0.41
▸ NLRP3 Q96P20 1/20 0.41
▸ PTGER1 P34995 1/20 0.41
▸ RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11024286 0.88 CYP1A2 (0.51) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL11024083 0.82 CYP1A2 (0.56) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL3057713 0.82 CYP1A2 (0.56) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL15071460 0.81 MAPT (0.49) CYP1A2CYP2C19ALDH1A1MEN1KMT2A
SCHEMBL11024043 0.79 CYP1A2 (0.52) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL3787132 0.79 CYP1A2 (0.73) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL11024734 0.79 SMN1; SMN2 (0.51) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL11021378 0.78 GRM5 (0.56) CYP1A2SMN1; SMN2ALDH1A1L3MBTL1GRM5
SCHEMBL6333143 0.78 MAPT (0.63) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL11025115 0.78 SMN1; SMN2 (0.73) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0040418-B1 PROCESS FOR PREPARING AN 1H-INDAZOL-3-YLACETIC ACID DERIVATIVE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-07-03 — — EP disclosed
EP-0040418-A1 Process for preparing an 1H-indazol-3-ylacetic acid derivative FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-11-25 — — EP disclosed
EP-0008759-A2 New process for preparing an 1H-indazol-3-ylacetic acid derivative FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-03-19 — — EP disclosed
Send feedback